Fanale, D.; Incorvaia, L.; Filorizzo, C.; Bono, M.; Fiorino, A.; Calò, V.; Brando, C.; Corsini, L.R.; Barraco, N.; Badalamenti, G.;
et al. Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2. Cancers 2020, 12, 2415.
https://doi.org/10.3390/cancers12092415
AMA Style
Fanale D, Incorvaia L, Filorizzo C, Bono M, Fiorino A, Calò V, Brando C, Corsini LR, Barraco N, Badalamenti G,
et al. Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2. Cancers. 2020; 12(9):2415.
https://doi.org/10.3390/cancers12092415
Chicago/Turabian Style
Fanale, Daniele, Lorena Incorvaia, Clarissa Filorizzo, Marco Bono, Alessia Fiorino, Valentina Calò, Chiara Brando, Lidia Rita Corsini, Nadia Barraco, Giuseppe Badalamenti,
and et al. 2020. "Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2" Cancers 12, no. 9: 2415.
https://doi.org/10.3390/cancers12092415
APA Style
Fanale, D., Incorvaia, L., Filorizzo, C., Bono, M., Fiorino, A., Calò, V., Brando, C., Corsini, L. R., Barraco, N., Badalamenti, G., Russo, A., & Bazan, V.
(2020). Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2. Cancers, 12(9), 2415.
https://doi.org/10.3390/cancers12092415